Cargando…

Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients

BACKGROUND: Young implantable cardioverter-defibrillator (ICD) patients are prone to complications and inappropriate shocks (IAS). The subcutaneous ICD (S-ICD) may avoid lead-related complications. This study aims to describe the incidence and nature of device-related complications in young transven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quast, A. B. E., Brouwer, T. F., Kooiman, K. M., van Dessel, P. F. H. M, Blom, N. A., Wilde, A. A. M., Knops, R. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288033/ https://www.ncbi.nlm.nih.gov/pubmed/30377940 http://dx.doi.org/10.1007/s12471-018-1186-1

Ejemplares similares

Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement
por: de Veld, Jolien A, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
por: van der Stuijt, W., et al.
Publicado: (2020)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

Long‐term follow‐up of the two‐incision implantation technique for the subcutaneous implantable cardioverter‐defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Comparison of quality-of-life measures in patients with transvenous and subcutaneous implantable cardioverter-defibrillators
por: Ferrick, Aileen M., et al.
Publicado: (2023)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Complications related to elective generator replacement of the subcutaneous implantable defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients
por: Baalman, S. W. E., et al.
Publicado: (2018)

Epicardial vs. transvenous implantable cardioverter defibrillators in children
por: Le Bos, Pierre Antoine, et al.
Publicado: (2023)

Transvenous shock‐only implantable cardioverter defibrillator after an atrio‐pulmonary Fontan surgery
por: Toyohara, Keiko, et al.
Publicado: (2020)

Mobile subcutaneous implantable cardioverter-defibrillator leads to oversensing and inappropriate shocks
por: Kiamanesh, Omid, et al.
Publicado: (2019)

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator
por: Al-Khatib, Sana M., et al.
Publicado: (2016)

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
por: Lambiase, Pier D., et al.
Publicado: (2020)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
por: Lambiase, Pier D, et al.
Publicado: (2022)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Transvenous Implantable Cardioverter-Defibrillator Lead Reliability: Implications for Postmarket Surveillance
por: Kramer, Daniel B, et al.
Publicado: (2015)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Revision of subcutaneous implantable cardioverter defibrillator to intermuscular pocket to prevent inappropriate shocks
por: Madjarov, Jeko M., et al.
Publicado: (2020)

Outpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres
por: Quast, A. F. B. E., et al.
Publicado: (2017)

Substernal subcutaneous implantable cardioverter-defibrillator lead placement for the management of inappropriate shocks
por: Do, Khuyen, et al.
Publicado: (2019)

Forces Applied during Transvenous Implantable Cardioverter Defibrillator Lead Removal
por: Lennerz, Carsten, et al.
Publicado: (2014)

State‐of‐the‐art consensus on non‐transvenous implantable cardioverter‐defibrillator therapy
por: Schukro, Christoph, et al.
Publicado: (2020)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

To the Editor— Strategy for revision of subcutaneous implantable cardioverter-defibrillator following inappropriate shock
por: Winter, Joachim, et al.
Publicado: (2019)

Successful repositioning of the subcutaneous implantable cardioverter‐defibrillator lead to avoid inappropriate shock
por: Fukunaga, Hiroshi, et al.
Publicado: (2023)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Air Entrapment Causing Inappropriate Shock From a Subcutaneous Implantable Cardioverter Defibrillator
por: Yang, Ying Chi, et al.
Publicado: (2019)

Process mapping strategies to prevent subcutaneous implantable cardioverter‐defibrillator infections
por: Weiss, Raul, et al.
Publicado: (2022)

Reply to the Editor— Strategy for revision of subcutaneous implantable cardioverter-defibrillator following inappropriate shock
por: Do, Khuyen, et al.
Publicado: (2019)

Sense-B-noise: an enigmatic cause for inappropriate shocks in subcutaneous implantable cardioverter defibrillators
por: Haeberlin, Andreas, et al.
Publicado: (2022)

Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
por: van Barreveld, M., et al.
Publicado: (2017)

Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_krf5bscj4nrbeleof4du7p66nl